Global Opioid-Induced Constipation Market Insights, Forecast to 2025
This report studies the Opioid-Induced Constipation market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Opioid-Induced Constipation market by product and Application/end industries.
In the last several years, global market of Opioid-Induced Constipation developed smoothly, with an average growth rate of 3.85% from the forecast period 2019 to 2025. In 2017, global revenue of Opioid-Induced Constipation is nearly 2112 M USD; the actual Sales is about 175.5 million units.
The major players in global market include
Takeda Pharmaceuticals
Bayer
Sanofi
Mallinckrodt
Salix (Bausch Health)
AstraZeneca
Progenics Pharmaceuticals
Purdue Pharm
Nektar Therapeutics
Daiichi Sankyo
Prestige
GSK
Shionogi
Geographically, this report split global into several key Regions, with sales and revenue, market share and growth rate of Opioid-Induced Constipation for these regions, from 2016 to 2025 (forecast)
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
Korea
Southeast Asia
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of Central & South America
Middle East & Africa
Middle East
Africa
Based on product, the Opioid-Induced Constipation market is primarily split into
Methylnaltrexone Bromide
Lubiprostone
Naloxegol
Others
On the basis on the end users/Application, this report covers
Hospital
Pharmacy
Other
- 1 Study Coverage
- 1.1 Opioid-Induced Constipation Product
- 1.2 Key Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Opioid-Induced Constipation Market Size Growth Rate by Type
- 1.4.2 Methylnaltrexone Bromide
- 1.4.3 Lubiprostone
- 1.4.4 Naloxegol
- 1.4.5 Others
- 1.5 Market by Application
- 1.5.1 Global Opioid-Induced Constipation Market Size Growth Rate by Application
- 1.5.2 Hospital
- 1.5.3 Pharmacy
- 1.6 Study Objectives
- 1.7 Years Considered
- 2 Executive Summary
- 2.1 Global Opioid-Induced Constipation Market Size
- 2.1.1 Global Opioid-Induced Constipation Revenue 2016-2025
- 2.1.2 Global Opioid-Induced Constipation Sales 2016-2025
- 2.2 Opioid-Induced Constipation Growth Rate by Regions
- 2.2.1 Global Opioid-Induced Constipation Sales by Regions
- 2.2.2 Global Opioid-Induced Constipation Revenue by Regions
- 3 Breakdown Data by Manufacturers
- 3.1 Opioid-Induced Constipation Sales by Manufacturers
- 3.1.1 Opioid-Induced Constipation Sales by Manufacturers
- 3.1.2 Opioid-Induced Constipation Sales Market Share by Manufacturers
- 3.2 Opioid-Induced Constipation Revenue by Manufacturers
- 3.2.1 Opioid-Induced Constipation Revenue by Manufacturers (2016-2018)
- 3.2.2 Opioid-Induced Constipation Revenue Share by Manufacturers (2016-2018)
- 3.2.3 Global Opioid-Induced Constipation Market Concentration Ratio
- 3.3 Opioid-Induced Constipation Price by Manufacturers
- 3.4 Opioid-Induced Constipation Headquarters, Product Types
- 3.4.1 Opioid-Induced Constipation Manufacturers Headquarters
- 3.4.2 Manufacturers Opioid-Induced Constipation Product Category
- 3.4.3 Establish Date of Manufacturers
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
- 4 Breakdown Data by Type
- 4.1 Global Opioid-Induced Constipation Sales by Type
- 4.2 Global Opioid-Induced Constipation Revenue by Type
- 4.3 Opioid-Induced Constipation Price by Type
- 5 Breakdown Data by Application
- 5.1 Overview
- 5.2 Global Opioid-Induced Constipation Breakdown Data by Application
- 6 North America
- 6.1 North America Opioid-Induced Constipation by Countries
- 6.1.1 North America Opioid-Induced Constipation Sales by Countries
- 6.1.2 North America Opioid-Induced Constipation Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Opioid-Induced Constipation by Type
- 6.3 North America Opioid-Induced Constipation by Application
- 6.4 North America Opioid-Induced Constipation by Company
- 7 Europe
- 7.1 Europe Opioid-Induced Constipation by Countries
- 7.1.1 Europe Opioid-Induced Constipation Sales by Countries
- 7.1.2 Europe Opioid-Induced Constipation Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Opioid-Induced Constipation by Type
- 7.3 Europe Opioid-Induced Constipation by Application
- 7.4 Europe Opioid-Induced Constipation by Company
- 8 Asia Pacific
- 8.1 Asia Pacific Opioid-Induced Constipation by Countries
- 8.1.1 Asia Pacific Opioid-Induced Constipation Sales by Countries
- 8.1.2 Asia Pacific Opioid-Induced Constipation Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Southeast Asia
- 8.2 Asia Pacific Opioid-Induced Constipation by Type
- 8.3 Asia Pacific Opioid-Induced Constipation by Application
- 8.4 Asia Pacific Opioid-Induced Constipation by Company
- 9 Central & South America
- 9.1 Central & South America Opioid-Induced Constipation by Countries
- 9.1.1 Central & South America Opioid-Induced Constipation Sales by Countries
- 9.1.2 Central & South America Opioid-Induced Constipation Revenue by Countries
- 9.1.3 Brazil
- 9.1.4 Argentina
- 9.2 Central & South America Opioid-Induced Constipation by Type
- 9.3 Central & South America Opioid-Induced Constipation by Application
- 9.4 Central & South America Opioid-Induced Constipation by Company
- 10 Middle East and Africa
- 10.1 Middle East and Africa Opioid-Induced Constipation by Countries
- 10.1.1 Middle East and Africa Opioid-Induced Constipation Sales by Countries
- 10.1.2 Middle East and Africa Opioid-Induced Constipation Revenue by Countries
- 10.1.3 Middle East
- 10.1.4 Africa
- 10.2 Middle East and Africa Opioid-Induced Constipation by Type
- 10.3 Middle East and Africa Opioid-Induced Constipation by Application
- 10.4 Middle East and Africa Opioid-Induced Constipation by Company
- 11 Analysis of Opioid-Induced Constipation Industry Key Manufacturers
- 11.1 Takeda Pharmaceuticals
- 11.1.1 Company Profile
- 11.1.2 Product Information
- 11.1.3 Sales, Price and Revenue
- 11.2 Bayer
- 11.2.1 Company Profile
- 11.2.2 Product Information
- 11.2.3 Sales, Price and Revenue
- 11.3 Sanofi
- 11.3.1 Company Profile
- 11.3.2 Product Information
- 11.3.3 Sales, Price and Revenue
- 11.4 Mallinckrodt
- 11.4.1 Company Profile
- 11.4.2 Product Information
- 11.4.3 Sales, Price and Revenue
- 11.5 Salix (Bausch Health)
- 11.5.1 Company Profile
- 11.5.2 Product Information
- 11.5.3 Sales, Price and Revenue
- 11.6 AstraZeneca
- 11.6.1 Company Profile
- 11.6.2 Product Information
- 11.6.3 Sales, Price and Revenue
- 11.7 Progenics Pharmaceuticals
- 11.7.1 Company Profile
- 11.7.2 Product Information
- 11.7.3 Sales, Price and Revenue
- 11.8 Purdue Pharm
- 11.8.1 Company Profile
- 11.8.2 Product Information
- 11.8.3 Sales, Price and Revenue
- 11.9 Nektar Therapeutics
- 11.9.1 Company Profile
- 11.9.2 Product Information
- 11.9.3 Sales, Price and Revenue
- 11.10 Daiichi Sankyo
- 11.10.1 Company Profile
- 11.10.2 Product Information
- 11.10.3 Sales, Price and Revenue
- 11.11 Prestige
- 11.11.1 Company Profile
- 11.11.2 Product Information
- 11.11.3 Sales, Price and Revenue
- 11.12 GSK
- 11.12.1 Company Profile
- 11.12.2 Product Information
- 11.12.3 Sales, Price and Revenue
- 11.13 Shionogi
- 11.13.1 Company Profile
- 11.13.2 Product Information
- 11.13.3 Sales, Price and Revenue
- 12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 12.1 Market Opportunities and Drivers
- 12.2 Market Challenges
- 12.3 Key World Economic Indicators
- 13 Value Chain and Sales Channels Analysis
- 13.1 Value Chain Analysis
- 13.1.1 Opioid-Induced Constipation Drugs R&D Cost Analysis
- 13.1.2 Opioid-Induced Constipation Customers
- 13.2 Sales Channels Analysis
- 13.2.1 Sales Channels Analysis
- 13.2.2 Distributors
- 14 Research Findings and Conclusion
- 15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Author Details
- 15.3 Disclaimer
- List of Tables and Figures
- Figure Opioid-Induced Constipation Product Picture
- Table Opioid-Induced Constipation Key Market Segments
- Table Key Manufacturers Opioid-Induced Constipation Covered in 2017
- Table Global Opioid-Induced Constipation Comparison by Types
- Table Global Opioid-Induced Constipation Market by Type (2017-2025) (K Unit) & (Million US$)
- Figure Global Opioid-Induced Constipation Sales Market Share by Type in 2017
- Figure Methylnaltrexone Bromide Product Picture
- Figure Lubiprostone Product Picture
- Figure Naloxegol Product Picture
- Figure Others Product Picture
- Table Global Opioid-Induced Constipation Market by Application (2018-2025) (K Unit)
- Figure Hospital
- Figure Pharmacy
- Figure Opioid-Induced Constipation Report Years Considered
- Figure Global Opioid-Induced Constipation Market Size 2016-2025 (Million US$)
- Figure Global Opioid-Induced Constipation Sales 2016-2025 (K Unit)
- Table Global Opioid-Induced Constipation Market Size by Regions 2016-2025 (K Unit) & (Million US$)
- Table Global Opioid-Induced Constipation Sales by Regions 2016-2025 (K Unit)
- Table Global Opioid-Induced Constipation Sales Market Share by Regions 2016-2025
- Figure Global Opioid-Induced Constipation Sales Market Share by Regions 2016-2025
- Figure 2017 Global Opioid-Induced Constipation Sales Market Share by Regions
- Table Global Opioid-Induced Constipation Revenue by Regions 2016-2025 (Million US$)
- Table Global Opioid-Induced Constipation Revenue Market Share by Regions 2016-2025
- Figure Global Opioid-Induced Constipation Revenue Market Share by Regions 2016-2025
- Figure Global Opioid-Induced Constipation Revenue Market Share by Regions in 2017
- Table Global Opioid-Induced Constipation Sales by Manufacturers (2016-2018) (K Unit)
- Table Global Opioid-Induced Constipation Sales Share by Manufacturers (2016-2018)
- Figure Global Opioid-Induced Constipation Sales Share by Manufacturers in 2017
- Table Opioid-Induced Constipation Revenue by Manufacturers (2016-2018) (Million US$)
- Table Opioid-Induced Constipation Revenue Share by Manufacturers (2016-2018)
- Figure Opioid-Induced Constipation Revenue Share by Manufacturers in 2017
- Figure 2017 Opioid-Induced Constipation Revenue Market Share by Manufacturers
- Figure 2017 Opioid-Induced Constipation Revenue Market Share of Top 6 Manufacturers
- Table Key Manufacturers Opioid-Induced Constipation Price (2016-2018) (USD/Unit)
- Table Opioid-Induced Constipation Manufacturers Headquarters
- Table Manufacturers Opioid-Induced Constipation Product Category
- Table Establish Date Manufacturers
- Table Manufacturers Mergers & Acquisitions, Expansion Plans
- Table Global Opioid-Induced Constipation Sales by Type (2016-2025) (K Unit)
- Table Global Opioid-Induced Constipation Sales Share by Type (2016-2025)
- Figure Global Opioid-Induced Constipation Sales Market Share by Type (2016-2025)
- Figure Global Opioid-Induced Constipation Sales Market Share by Type in 2017
- Table Global Opioid-Induced Constipation Revenue by Type (2016-2025) (Million US$)
- Table Global Opioid-Induced Constipation Revenue Share by Type (2016-2025)
- Figure Global Opioid-Induced Constipation Revenue Market Share by Type (2016-2025)
- Figure Global Opioid-Induced Constipation Revenue Market Share by Type in 2017
- Table Opioid-Induced Constipation Price by Type 2016-2015(USD/Unit)
- Figure Global Sales Opioid-Induced Constipation Market Share by Application in 2017
- Table Global Opioid-Induced Constipation Sales by Application (2016-2025) (K Unit)
- Table Global Opioid-Induced Constipation Sales Share by Application (2016-2025)
- Figure Global Sales Opioid-Induced Constipation Market Share by Application (2016-2025)
- Figure Global Sales Opioid-Induced Constipation Market Share by Application in 2017
- Figure North America Opioid-Induced Constipation Sales Growth Rate 2016-2025 (K Unit)
- Figure North America Opioid-Induced Constipation Revenue Growth Rate 2016-2025 (Million US$)
- Table North America Opioid-Induced Constipation Sales by Countries (2016-2025) (K Unit)
- Table North America Opioid-Induced Constipation Sales Market Share by Countries (2016-2025)
- Figure North America Opioid-Induced Constipation Sales Market Share by Countries in 2017
- Table North America Opioid-Induced Constipation Revenue by Countries (2016-2025) (Million US$)
- Table North America Opioid-Induced Constipation Revenue Market Share by Countries (2016-2025)
- Figure North America Opioid-Induced Constipation Revenue Market Share by Countries in 2017
- Figure United States Opioid-Induced Constipation Sales Growth Rate (2016-2025) (K Unit)
- Figure United States Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
- Figure Canada Opioid-Induced Constipation Sales Growth Rate (2016-2025) (K Unit)
- Figure Canada Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
- Figure Mexico Opioid-Induced Constipation Sales Growth Rate (2016-2025) (K Unit)
- Figure Mexico Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
- Table North America Opioid-Induced Constipation Sales by Type (2016-2025) (K Unit)
- Table North America Opioid-Induced Constipation Sales Market Share by Type (2016-2025)
- Figure 2017 North America Opioid-Induced Constipation Market Share by Type
- Table North America Opioid-Induced Constipation Sales by Application (2016-2025) (K Unit)
- Table North America Opioid-Induced Constipation Sales Market Share by Application (2016-2025)
- Figure 2017 North America Opioid-Induced Constipation Market Share by Application
- Table North America Opioid-Induced Constipation Sales by Company (2016-2018) (K Unit)
- Table North America Opioid-Induced Constipation Sales Market Share by Company (2016-2018)
- Figure North America Opioid-Induced Constipation Sales Market Share by Company in 2017
- Figure Europe Opioid-Induced Constipation Sales Growth Rate 2016-2025 (K Unit)
- Figure Europe Opioid-Induced Constipation Revenue Growth Rate 2016-2025 (Million US$)
- Table Europe Opioid-Induced Constipation Sales by Countries (2016-2025) (K Unit)
- Table Europe Opioid-Induced Constipation Sales Market Share by Countries (2016-2025)
- Figure 2017 Europe Opioid-Induced Constipation Sales Market Share by Countries
- Table Europe Opioid-Induced Constipation Revenue by Countries (2016-2025) (Million US$)
- Table Europe Opioid-Induced Constipation Revenue Market Share by Countries (2016-2025)
- Figure 2017 Europe Opioid-Induced Constipation Revenue Market Share by Countries
- Figure Germany Opioid-Induced Constipation Sales Growth Rate (2016-2025) (K Unit)
- Figure Germany Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
- Figure France Opioid-Induced Constipation Sales Growth Rate (2016-2025) (K Unit)
- Figure France Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
- Figure UK Opioid-Induced Constipation Sales Growth Rate (2016-2025) (K Unit)
- Figure UK Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
- Figure Italy Opioid-Induced Constipation Sales Growth Rate (2016-2025) (K Unit)
- Figure Italy Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
- Figure Russia Opioid-Induced Constipation Sales Growth Rate (2016-2025) (K Unit)
- Figure Russia Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
- Table Europe Opioid-Induced Constipation Sales by Type (2016-2025) (K Unit)
- Table Europe Opioid-Induced Constipation Sales Market Share by Type (2016-2025)
- Figure 2017 Europe Opioid-Induced Constipation Market Share by Type
- Table Europe Opioid-Induced Constipation Sales by Application (2016-2025) (K Unit)
- Table Europe Opioid-Induced Constipation Sales Market Share by Application (2016-2025)
- Figure 2017 Europe Opioid-Induced Constipation Market Share by Application
- Table Europe Opioid-Induced Constipation Sales by Company (2016-2018) (K Unit)
- Table Europe Opioid-Induced Constipation Sales Market Share by Company (2016-2018)
- Figure Europe Opioid-Induced Constipation Sales Market Share by Company in 2017
- Figure Asia Pacific Opioid-Induced Constipation Sales Growth Rate 2016-2025 (K Unit)
- Figure Asia Pacific Opioid-Induced Constipation Revenue Growth Rate 2016-2025 (Million US$)
- Table Asia Pacific Opioid-Induced Constipation Sales by Countries (2016-2025) (K Unit)
- Table Asia Pacific Opioid-Induced Constipation Sales Market Share by Countries (2016-2025)
- Figure 2017 Asia Pacific Opioid-Induced Constipation Sales Market Share by Countries
- Table Asia Pacific Opioid-Induced Constipation Revenue by Countries (2016-2025) (Million US$)
- Table Asia Pacific Opioid-Induced Constipation Revenue Market Share by Countries (2016-2025)
- Figure 2017 Asia Pacific Opioid-Induced Constipation Revenue Market Share by Countries
- Figure China Opioid-Induced Constipation Sales Growth Rate (2016-2025) (K Unit)
- Figure China Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
- Figure Japan Opioid-Induced Constipation Sales Growth Rate (2016-2025) (K Unit)
- Figure Japan Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
- Figure Korea Opioid-Induced Constipation Sales Growth Rate (2016-2025) (K Unit)
- Figure Korea Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
- Figure India Opioid-Induced Constipation Sales Growth Rate (2016-2025) (K Unit)
- Figure India Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
- Figure Southeast Asia Opioid-Induced Constipation Sales Growth Rate (2016-2025) (K Unit)
- Figure Southeast Asia Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
- Table Asia Pacific Opioid-Induced Constipation Sales by Type (2016-2025) (K Unit)
- Table Asia Pacific Opioid-Induced Constipation Sales Market Share by Type (2016-2025)
- Figure 2017 Asia Pacific Opioid-Induced Constipation Market Share by Type
- Table Asia Pacific Opioid-Induced Constipation Sales by Application (2016-2025) (K Unit)
- Table Asia Pacific Opioid-Induced Constipation Sales Market Share by Application (2016-2025)
- Figure 2017 Asia Pacific Opioid-Induced Constipation Market Share by Application
- Table Asia Pacific Opioid-Induced Constipation Sales by Company (2016-2018) (K Unit)
- Table Asia Pacific Opioid-Induced Constipation Sales Market Share by Company (2016-2018)
- Figure Asia Pacific Opioid-Induced Constipation Sales Market Share by Company in 2017
- Figure Central & South America Opioid-Induced Constipation Sales Growth Rate 2016-2025 (K Units)
- Figure Central & South America Opioid-Induced Constipation Revenue Growth Rate 2016-2025 (Million US$)
- Table Central & South America Opioid-Induced Constipation Sales by Countries (2016-2025) (K Units)
- Table Central & South America Opioid-Induced Constipation Sales Market Share by Countries (2016-2025)
- Figure 2017 Central & South America Opioid-Induced Constipation Sales Market Share by Countries
- Table Central & South America Opioid-Induced Constipation Revenue by Countries (2016-2025) (Million US$)
- Table Central & South America Opioid-Induced Constipation Revenue